Shortly after Kentucky announced its new work requirements for the Medicaid program, a lawsuit was brought by residents against the government. Sara Rosenbaum, JD, the Harold and Jane Hirsh Professor of Health Law and Policy and founding chair of the Department of Health Policy at the Milken Institute School of Public Health, George Washington University, explains what other states looking to implement work requirements might face.
Shortly after Kentucky announced its new work requirements for the Medicaid program, a lawsuit was brought by residents against the government. Sara Rosenbaum, JD, the Harold and Jane Hirsh Professor of Health Law and Policy and founding chair of the Department of Health Policy at the Milken Institute School of Public Health, George Washington University, explains what this lawsuit might mean for other states looking to implement work requirements.
Transcript
Kentucky residents have already brought a lawsuit against the government for the state’s Medicaid work requirement; do you expect this will be the result for most states that try to implement work requirements?
No, I don’t. I think that Kentucky represents a particularly severe version of work requirement. As I say, I expect that in Virginia it may be that this opens a door for us and that they will negotiate some combination of work supports as a part of a Medicaid expansion—while they may not be my first choice, are not supports that beneficiaries and potential beneficiaries don’t think they can live with.
Kentucky is quite unique because here’s a state that simply did an expansion and brought half million people into its program and the results have been what you would think in terms of care and access. There are clearly costs that the state has now because of the expansion that it didn’t have in the beginning but that’s a different set of problems from just deciding you’re going to A) remove 1000 people and B) you’re going to make the program so hard to get into that people won’t enroll.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More